The degree of dysplasia in patients with Barrett’s esophagus (BE) is key to determining the application of BE endoscopic therapy and assigning surveillance intervals. Multiple
low-grade dysplasia
low-grade dysplasia
Artificial Intelligence Detects Dysplasia in Histopathology Slides From Patients With Barrett’s Esophagus
Progression in Barrett’s Esophagus Score Can Be Used for Estimating Neoplastic Progression
Barrett’s esophagus (BE) is a known precancerous lesion for esophageal dysplasia and adenocarcinoma (EAC); however, it is unclear who will progress to high-grade dysplasia (HGD)
